TRAIL binds to death receptors to induce apoptosis and is highly selective towards cancer cells, but aberrant PI3K/Akt pathway activity, common in cancer cells [249], can also lead to TRAIL resistance [266]. This evidence concerns the gene TNFSF10 and cancer.